1. Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement
- Author
-
Erik Melén, Edward F Knol, Karin Hoffmann-Sommergruber, N. Khaltaev, Bolesław Samoliński, Cezmi A. Akdis, Claus Bachert, Hui Du, Sinthia Bosnic-Anticevich, Maria Teresa Ventura, Ruby Pawankar, Mohamed H. Shamji, Mübeccel Akdis, Ken Ohta, Joaquim Mullol, Jean Bousquet, Robert M. Naclerio, Ioana Agache, Tari Haahtela, Arunas Valiulis, Sanna Toppila-Salmi, I. J. Ansotegui, J. C. Ivancevich, Oliver Pfaar, Giorgio Walter Canonica, Gabrielle L. Onorato, Ya-dong Gao, Alvaro A. Cruz, Anna Bedbrook, Stefano Del Giacco, Yoshitaka Okamoto, Marek Jutel, P. M. Matricardi, Nikos G Papadopoulos, Wiencyslawa Czarlewski, João Fonseca, D. Larenas-Linnemann, Piotr Kuna, Tomas Chivato, Arzu Yorgancioglu, Jürgen Schwarze, Torsten Zuberbier, Ludger Klimek, Liam O'Mahony, Center for Rhinology and Allergology, Wiesbaden, Germany, Department of Clinical Immunology, Wrocław Medical University, ALL-MED Medical Research Institute, Poland, Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland, Universitätsmedizin Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, CharitéHumboldt-Universität zu BerlinBerlin, Germany, University Hospital, Montpellier, France, MACVIA-France, Montpellier, France, Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium, Transylvania University BrasovBrasov, Romania, Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain, Woolcock Institute of Medical Research, University of Sydney and Woolcock Emphysema Centre and Sydney Local Health District, NSW, Australia, Personalized Medicine Clinic Asthma & Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italy, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Rozzano, MI, Italy, School of Medicine, University CEU San PabloMadrid, Spain, ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Planning Group, Salvador, Brazil, Medical Consulting Czarlewski, Montpellier, France, Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital 'Duilio Casula', University of Cagliari, Cagliari, Italy, Department of Respiratory Medicine, Wuhan Children's Hospital, Tongji Medical College, University of Science and Technology, Wuhan, Hubei, China, Center for research in health technologies and information systems- CINTESIS, Universidade do PortoPorto, Portugal, Allergy Unit, Instituto CUF Porto e Hospital CUF PortoPorto, Portugal, Health Information and Decision Sciences Department - CIDES, Faculdade de Medicina, Universidade do PortoPorto, Portugal, Faculdade de Medicina da Universidade do PortoPorto, Portugal, Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland, Department of Pathophysiology and Allergy Research, Medical University of ViennaVienna, Austria, Servicio de Alergia e Immunologia, Clinica Santa Isabel, Aires, Argentina, Geneva, Switzerland, Departments of Immunology and Dermatology/Allergology, University Medical CenterUtrecht, Netherlands, Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland, Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and HospitalMéxico City, Mexico, Institute of Environmental Medicine, Karolinska Institutet and Sachs' Children's HospitalStockholm, Sweden, Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain, Johns Hopkins School of Medicine, Baltimore, MD, United States, National Hospital Organization, Tokyo National HospitalTokyo, Japan, Dept of Otorhinolaryngology, Chiba University HospitalChiba, Japan, Departments of Medicine and Microbiology, University College Cork, Cork, Ireland, Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of ManchesterManchester, United Kingdom, Department of Pediatrics, Nippon Medical SchoolTokyo, Japan, Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Germany, Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland, Centre for Inflammation Research, Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom, Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London. Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom, University of Bari Medical School, Unit of Geriatric ImmunoallergologyBari, Italy, Vilnius University, Faculty of Medicine, Institute of Clinical Medicine &, Institute of Health SciencesVilnius, Lithuania, European Academy of Paediatrics, Brussels, Belgium, Celal Bayar University, Department of PulmonologyManisa, Turkey, Charité - Universitätsmedizin BerlinBerlin, Germany, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and AllergyBerlin, Germany, Klimek, Ludger, Jutel, Marek, Akdis, Cezmi, Bousquet, Jean, Akdis, Mübeccel, Bachert, Clau, Agache, Ioana, Ansotegui, Ignacio, Bedbrook, Anna, Bosnic-Anticevich, Sinthia, Canonica, Giorgio W, Chivato, Toma, Cruz, Alvaro A, Czarlewski, Wiencyslawa, Giacco, Stefano Del, Du, Hui, Fonseca, Joao A, Gao, Yadong, Haahtela, Tari, Hoffmann-Sommergruber, Karin, Ivancevich, Juan-Carlo, Iaccarino, Guido, Khaltaev, Nikolai, Knol, Edward F, Kuna, Piotr, Larenas-Linnemann, Desiree, Melen, Erik, Mullol, Joaquim, Naclerio, Robert, Ohta, Ken, Okamoto, Yoshitaka, O'Mahony, Liam, Onorato, Gabrielle L, Papadopoulos, Nikos G, Pawankar, Ruby, Pfaar, Oliver, Samolinski, Boleslaw, Schwarze, Jurgen, Toppila-Salmi, Sanna, Shamji, Mohamed H, Ventura, Maria Teresa, Valiulis, Aruna, Yorgancioglu, Arzu, Matricardi, Paolo, Zuberbier, Torsten, Department of Dermatology, Allergology and Venereology, HUS Inflammation Center, and Department of Pathology
- Subjects
0301 basic medicine ,Allergy ,Eaaci Position Paper ,CD8-Positive T-Lymphocytes ,Social life ,0302 clinical medicine ,clinical immunotherapy ,Pandemic ,Immunology and Allergy ,Infection control ,AIT ,Treatment options ,3. Good health ,Coronavirus Infections ,Allergen immunotherapy ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Immunology ,Eaaci Position Papers ,MECHANISMS ,Betacoronavirus ,03 medical and health sciences ,Allergists ,Th2 Cells ,VACCINES ,allergy treatment ,medicine ,VENOM ALLERGY ,Humans ,Intensive care medicine ,Pandemics ,Infection Control ,Sublingual Immunotherapy ,immunotherapy vaccines and mechanisms ,SARS-CoV-2 ,business.industry ,COVID-19 ,Immunoglobulin E ,medicine.disease ,Rhinitis, Allergic ,Asthma ,Allergen-specific immunotherapy ,Coronavirus ,Eosinophils ,030104 developmental biology ,Immunoglobulin M ,030228 respiratory system ,3121 General medicine, internal medicine and other clinical medicine ,business - Abstract
The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.
- Published
- 2020
- Full Text
- View/download PDF